Below are the financial statements of Biohaven, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
| All figures in millions of USD | 2024 as of 2024-12-31 | 2023 as of 2023-12-31 |
|---|---|---|
| Assets | — | — |
| Current assets | — | — |
| Cash and cash equivalents | 99.13a | 248.4a |
| Marketable securities | 386.86a | 133.42a |
| Prepaid expenses | 49.38a | 35.24a |
| Income tax receivable | 2.6a | 13.25a |
| Other current assets | 0.51a | 12.13a |
| Total current assets | 538.47a | 442.45a |
| Property and equipment, net | 17.32a | 17.19a |
| Intangible assets | 18.4a | 18.4a |
| Goodwill | 1.39a | 1.39a |
| Other non-current assets | 39.53a | 33.79a |
| Total assets | 615.11a | 513.21a |
| Liabilities and shareholders' equity | — | — |
| Current liabilities | — | — |
| Accounts payable | 18.03a | 15.58a |
| Accrued expenses and other current liabilities | 51.49a | 39.85a |
| Forward contract and derivative liability | 84.71a | 0a |
| Total current liabilities | 154.23a | 55.42a |
| Non-current operating lease liability | 32.78a | 27.57a |
| Other non-current liabilities | 4.66a | 2.25a |
| Total liabilities | 191.67a | 85.24a |
| Shareholders' equity | — | — |
| Preferred shares | 0a | 0a |
| Common shares | 1,656.7a | 887.53a |
| Additional paid-in capital | 112.37a | 39.8a |
| Accumulated deficit | -1,345.71a | -499.29a |
| Accumulated other comprehensive income (loss) | 0.08a | -0.07a |
| Total shareholders' equity | 423.44a | 427.98a |
| Total liabilities and shareholders' equity | 615.11a | 513.21a |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Biohaven’s data sources below and access millions more through our Disclosure Search.